Nov 07, 2017 8:00am EST OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform
Nov 03, 2017 9:43am EDT OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017
Oct 26, 2017 10:19am EDT OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy
Oct 12, 2017 8:00am EDT OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE® in Japan
Sep 19, 2017 8:00am EDT OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care
Sep 12, 2017 8:30am EDT OPKO’s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings
Aug 03, 2017 8:00am EDT OPKO Health to Announce 2017 Second Quarter Financial Results on August 8, 2017